Search
Menu
Home
HTB
2022
September
HTB
September 2022
Contents
Editorial
HTB September 2022 (1 September 2022)
Special reports
Update on monkeypox in the UK: reduced cases, vaccine access, transmission and treatment…
Conference reports
24th International AIDS Conference (AIDS 2022)
Dolutegravir no longer linked to higher risk of neural tube defects: latest update from the Tsepamo study
Weight gain with dolutegravir and TAF in ADVANCE study continues out to week 192
VRC01 added to early ART in infants did not reduce viral reservoir
Using PrEP during pregnancy is safe for children
Long-acting CAB/RPV injections have a similar weight and lipid profile to dolutegravir-based oral ART
Montreal’s response to monkeypox: rapid vaccine rollout, 39 breakthrough infections
Summary of 620 cases of monkeypox seen at three London clinics
Advances in HIV cure-related research: IAS workshop now online
Antiretrovirals
Lenacapavir approved in the EU and UK to treat multidrug resistant HIV
mpox (monkeypox)
US survey reports 50% of gay men changed sexual behaviour to avoid monkeypox
US model limits monkeypox infections by one-third from having fewer one-time partners: short-term strategy until next vaccine supply
BHIVA include efficacy data on HIV and monkeypox vaccine: updated statement (August 2022)
Monkeypox DNA detected in anal samples of asymptomatic men in Paris and Belgium
Unusual case reports: non-sexual acquisition, severe MPX and advanced HIV, human-to-dog transmission
Tecovirimat for treating mild monkeypox: new studies open in the UK and US
US cases: MMWR report on 1891 cases to 22 July 2022
Monkeypox transmission in heterosexual couples in Nigeria
Access to vaccines and treatment for pregnant women at risk of monkeypox
MPX DNA easily detected on surfaces in hospital after cleaning
Understanding HIV and monkeypox coinfection: NEAT/EACS dashboard
HIV prevention and transmission
HIV seroconversions on PrEP in Australian study are linked to low adherence
PDFs
HTB: no. 9 (3 September 2022) PDF download
HTB RSS
Early access
HIV guidelines recommend a statin for all people older than 40: new BHIVA document
21 November 2023
Dolutegravir monotherapy still not recommended: 4-year follow up in early-treated durably suppressed participants
12 November 2023
CHAI 2023 market report: decline in HIV funding threatens 20 years of progress
2 November 2023
Mpox vaccines still available and recommended in the UK and US
2 November 2023
All early access reports
Current issues
November 2023
October 2023
September 2023
Back issues
Special report
Uganda report: Increase in LGBTQI+ assaults and human rights violations need urgent activist responses
1 October 2023
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage